Full Text of SB1805 97th General Assembly
SB1805 97TH GENERAL ASSEMBLY |
| | 97TH GENERAL ASSEMBLY
State of Illinois
2011 and 2012 SB1805 Introduced 2/9/2011, by Sen. Pamela J. Althoff SYNOPSIS AS INTRODUCED: |
| |
Amends the Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois. In the provision concerning Multidrug-Resistant Organisms (MDROs), requires the Department to publish a yearly report regarding certain MDRO infections based on a surveillance system substantially similar to the Center for Disease Control and Prevention's National Healthcare Safety Network surveillance system (instead of the Hospital Discharge Dataset).
|
| |
| | A BILL FOR |
|
| | | SB1805 | | LRB097 05294 RPM 45348 b |
|
| 1 | | AN ACT concerning public health.
| 2 | | Be it enacted by the People of the State of Illinois,
| 3 | | represented in the General Assembly:
| 4 | | Section 5. The Department of Public Health Powers and | 5 | | Duties Law of the
Civil Administrative Code of Illinois is | 6 | | amended by changing Section 2310-312 as follows: | 7 | | (20 ILCS 2310/2310-312) | 8 | | Sec. 2310-312. Multidrug-Resistant Organisms. The | 9 | | Department shall perform the following functions in relation to | 10 | | the prevention and control of Multidrug-Resistant Organisms | 11 | | (MDROs), including methicillin-resistant Staphylococcus aureus | 12 | | (MRSA), vancomycin-resistant (VRE) and certain gram-negative | 13 | | bacilli (GNB), as these terms are referenced by the United | 14 | | States Centers for Disease Control and Prevention: | 15 | | (1) Except with regard to hospitals, for which | 16 | | administrative rules shall be adopted in accordance with | 17 | | Section 6.23 of the Hospital Licensing Act and Section 7 of | 18 | | the University of Illinois Hospital Act, the Department | 19 | | shall adopt administrative rules for health care | 20 | | facilities subject to licensure, certification, | 21 | | registration, or other regulation by the Department that | 22 | | may require one or more types of those facilities to (i) | 23 | | perform an annual infection control risk assessment, (ii) |
| | | SB1805 | - 2 - | LRB097 05294 RPM 45348 b |
|
| 1 | | develop infection control policies for MDROs that are based | 2 | | on this assessment and incorporate, as appropriate, | 3 | | updated recommendations of the U.S. Centers for Disease | 4 | | Control and Prevention for the prevention and control of | 5 | | MDROs, and (iii) enforce hand hygiene requirements. | 6 | | (2) The Department shall: | 7 | | (A) publicize guidelines for reducing the | 8 | | incidence of MDROs to health care providers, health | 9 | | care facilities, public health departments, prisons, | 10 | | jails, and the general public; and | 11 | | (B) provide periodic reports and updates to public | 12 | | officials, health professionals, and the general | 13 | | public statewide regarding new developments or | 14 | | procedures concerning prevention and management of | 15 | | infections due to MDROs. | 16 | | (3) The Department shall publish a yearly report | 17 | | regarding MRSA and Clostridium difficile infections based | 18 | | on a surveillance system substantially similar to the | 19 | | Center for Disease Control and Prevention's National | 20 | | Healthcare Safety Network surveillance system the Hospital | 21 | | Discharge Dataset . The Department is authorized to require | 22 | | hospitals, based on guidelines developed by the National | 23 | | Center for Health Statistics, after October 1, 2007, to | 24 | | submit data to the Department that is coded as "present on | 25 | | admission" and "occurred during the stay". | 26 | | (4) Reporting to the Department under the Hospital |
| | | SB1805 | - 3 - | LRB097 05294 RPM 45348 b |
|
| 1 | | Report Card Act shall include organisms, including but not | 2 | | limited to MRSA, that are responsible for central venous | 3 | | catheter-associated bloodstream infections and | 4 | | ventilator-associated pneumonia in designated hospital | 5 | | units. | 6 | | (5) The Department shall implement surveillance for | 7 | | designated cases of community associated MRSA infections | 8 | | for a period of at least 3 years, beginning on or before | 9 | | January 1, 2008.
| 10 | | (Source: P.A. 95-282, eff. 8-20-07.)
|
|